Cargando…

HR-MS Based Untargeted Lipidomics Reveals Characteristic Lipid Signatures of Wilson’s Disease

Background and Aims: The diagnosis of Wilson’s disease (WD) is challenging by clinical or genetic criteria. A typical early pathological change of WD is the increased liver lipid deposition and lowered serum triglyceride (TG). Therefore, the contents of serum lipids may provide evidence for screenin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhi, Yixiao, Sun, Yujiao, Jiao, Yonggeng, Pan, Chen, Wu, Zeming, Liu, Chang, Su, Jie, Zhou, Jie, Shang, Dong, Niu, Junqi, Hua, Rui, Yin, Peiyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645799/
https://www.ncbi.nlm.nih.gov/pubmed/34880754
http://dx.doi.org/10.3389/fphar.2021.754185
_version_ 1784610384151314432
author Zhi, Yixiao
Sun, Yujiao
Jiao, Yonggeng
Pan, Chen
Wu, Zeming
Liu, Chang
Su, Jie
Zhou, Jie
Shang, Dong
Niu, Junqi
Hua, Rui
Yin, Peiyuan
author_facet Zhi, Yixiao
Sun, Yujiao
Jiao, Yonggeng
Pan, Chen
Wu, Zeming
Liu, Chang
Su, Jie
Zhou, Jie
Shang, Dong
Niu, Junqi
Hua, Rui
Yin, Peiyuan
author_sort Zhi, Yixiao
collection PubMed
description Background and Aims: The diagnosis of Wilson’s disease (WD) is challenging by clinical or genetic criteria. A typical early pathological change of WD is the increased liver lipid deposition and lowered serum triglyceride (TG). Therefore, the contents of serum lipids may provide evidence for screening of biomarkers for WD. Methods: 34 WD patients, 31 WD relatives, and 65 normal controls were enrolled in this study. Serum lipidomics data was acquired by an ultra-high-performance liquid chromatography high-resolution mass spectrometry system, and the data were analyzed by multivariate statistical methods. Results: Of all 510 identified lipids, there are 297 differential lipids between the WD and controls, 378 differential lipids between the relatives and controls, and 119 differential lipids between the patients and relatives. In WD, the abundances of most saturated TG were increased, whereas other unsaturated lipids decreased, including phosphatidylcholine (PC), sphingomyelin (SM), lysophosphatidylcholine (LPC), ceramide (Cer), and phosphatidylserine (PS). We also found many serum lipid species may be used as biomarkers for WD. The areas under the receiver operating characteristic curve (AUC) of PS (35:0), PS (38:5), and PS (34:0) were 0.919, 0.843, and 0.907. The AUCs of TG (38:0) and CerG1 (d42:2) were 0.948 and 0.915 and the AUCs of LPC (17:0) and LPC (15:0) were 0.980 and 0.960, respectively. The lipid biomarker panel exhibits good diagnostic performance for WD. The correlation networks were built among the different groups and the potential mechanisms of differential lipids were discussed. Interestingly, similar lipid profile of WD is also found in their relatives, which indicated the changes may also related to the mutation of the ATP7B gene. Conclusions: Lipid deregulation is another important hallmark of WD besides the deposition of copper. Our lipidomic results provide new insights into the diagnostic and therapeutic targets of WD.
format Online
Article
Text
id pubmed-8645799
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86457992021-12-07 HR-MS Based Untargeted Lipidomics Reveals Characteristic Lipid Signatures of Wilson’s Disease Zhi, Yixiao Sun, Yujiao Jiao, Yonggeng Pan, Chen Wu, Zeming Liu, Chang Su, Jie Zhou, Jie Shang, Dong Niu, Junqi Hua, Rui Yin, Peiyuan Front Pharmacol Pharmacology Background and Aims: The diagnosis of Wilson’s disease (WD) is challenging by clinical or genetic criteria. A typical early pathological change of WD is the increased liver lipid deposition and lowered serum triglyceride (TG). Therefore, the contents of serum lipids may provide evidence for screening of biomarkers for WD. Methods: 34 WD patients, 31 WD relatives, and 65 normal controls were enrolled in this study. Serum lipidomics data was acquired by an ultra-high-performance liquid chromatography high-resolution mass spectrometry system, and the data were analyzed by multivariate statistical methods. Results: Of all 510 identified lipids, there are 297 differential lipids between the WD and controls, 378 differential lipids between the relatives and controls, and 119 differential lipids between the patients and relatives. In WD, the abundances of most saturated TG were increased, whereas other unsaturated lipids decreased, including phosphatidylcholine (PC), sphingomyelin (SM), lysophosphatidylcholine (LPC), ceramide (Cer), and phosphatidylserine (PS). We also found many serum lipid species may be used as biomarkers for WD. The areas under the receiver operating characteristic curve (AUC) of PS (35:0), PS (38:5), and PS (34:0) were 0.919, 0.843, and 0.907. The AUCs of TG (38:0) and CerG1 (d42:2) were 0.948 and 0.915 and the AUCs of LPC (17:0) and LPC (15:0) were 0.980 and 0.960, respectively. The lipid biomarker panel exhibits good diagnostic performance for WD. The correlation networks were built among the different groups and the potential mechanisms of differential lipids were discussed. Interestingly, similar lipid profile of WD is also found in their relatives, which indicated the changes may also related to the mutation of the ATP7B gene. Conclusions: Lipid deregulation is another important hallmark of WD besides the deposition of copper. Our lipidomic results provide new insights into the diagnostic and therapeutic targets of WD. Frontiers Media S.A. 2021-11-22 /pmc/articles/PMC8645799/ /pubmed/34880754 http://dx.doi.org/10.3389/fphar.2021.754185 Text en Copyright © 2021 Zhi, Sun, Jiao, Pan, Wu, Liu, Su, Zhou, Shang, Niu, Hua and Yin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zhi, Yixiao
Sun, Yujiao
Jiao, Yonggeng
Pan, Chen
Wu, Zeming
Liu, Chang
Su, Jie
Zhou, Jie
Shang, Dong
Niu, Junqi
Hua, Rui
Yin, Peiyuan
HR-MS Based Untargeted Lipidomics Reveals Characteristic Lipid Signatures of Wilson’s Disease
title HR-MS Based Untargeted Lipidomics Reveals Characteristic Lipid Signatures of Wilson’s Disease
title_full HR-MS Based Untargeted Lipidomics Reveals Characteristic Lipid Signatures of Wilson’s Disease
title_fullStr HR-MS Based Untargeted Lipidomics Reveals Characteristic Lipid Signatures of Wilson’s Disease
title_full_unstemmed HR-MS Based Untargeted Lipidomics Reveals Characteristic Lipid Signatures of Wilson’s Disease
title_short HR-MS Based Untargeted Lipidomics Reveals Characteristic Lipid Signatures of Wilson’s Disease
title_sort hr-ms based untargeted lipidomics reveals characteristic lipid signatures of wilson’s disease
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645799/
https://www.ncbi.nlm.nih.gov/pubmed/34880754
http://dx.doi.org/10.3389/fphar.2021.754185
work_keys_str_mv AT zhiyixiao hrmsbaseduntargetedlipidomicsrevealscharacteristiclipidsignaturesofwilsonsdisease
AT sunyujiao hrmsbaseduntargetedlipidomicsrevealscharacteristiclipidsignaturesofwilsonsdisease
AT jiaoyonggeng hrmsbaseduntargetedlipidomicsrevealscharacteristiclipidsignaturesofwilsonsdisease
AT panchen hrmsbaseduntargetedlipidomicsrevealscharacteristiclipidsignaturesofwilsonsdisease
AT wuzeming hrmsbaseduntargetedlipidomicsrevealscharacteristiclipidsignaturesofwilsonsdisease
AT liuchang hrmsbaseduntargetedlipidomicsrevealscharacteristiclipidsignaturesofwilsonsdisease
AT sujie hrmsbaseduntargetedlipidomicsrevealscharacteristiclipidsignaturesofwilsonsdisease
AT zhoujie hrmsbaseduntargetedlipidomicsrevealscharacteristiclipidsignaturesofwilsonsdisease
AT shangdong hrmsbaseduntargetedlipidomicsrevealscharacteristiclipidsignaturesofwilsonsdisease
AT niujunqi hrmsbaseduntargetedlipidomicsrevealscharacteristiclipidsignaturesofwilsonsdisease
AT huarui hrmsbaseduntargetedlipidomicsrevealscharacteristiclipidsignaturesofwilsonsdisease
AT yinpeiyuan hrmsbaseduntargetedlipidomicsrevealscharacteristiclipidsignaturesofwilsonsdisease